文献速递多重用药老年综合评估

临床试验中药物不良撤药事件报告标准:一项系统综述

Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review.
PubMed 文献 · J Am Geriatr Soc · 2025-03-28

该系统综述检索了Ovid Medline、Embase和Cochrane Central Register of Controlled Trials(截至2024年7月2日),纳入139项在老年人(平均或中位年龄≥65岁)中测试处方精简干预的随机对照试验,仅12项报告了药物不良撤药事件(ADWE)。这12项研究采用6种方法捕捉ADWE,结论是极少处方精简研究系统捕捉ADWE且缺乏标准化报告。

要点

  • 在139项处方精简随机对照试验中,仅12项报告了药物不良撤药事件(ADWE)。
  • 报告ADWE的研究使用了6种不同的捕捉方法,缺乏统一标准。
  • 作者建议采用协调一致的方法和特定标准来捕捉ADWE,以改善结果一致性。

核心结论

  • 极少处方精简研究捕捉药物不良撤药事件(ADWE),且缺乏标准化报告。
  • 采用协调一致的方法和特定标准捕捉ADWE,可确保处方精简试验结果更一致,并促进未来荟萃分析。

研究设计与样本

  • 系统综述,遵循PRISMA清单,检索Ovid Medline、Embase和Cochrane Central Register of Controlled Trials从建库至2024年7月2日。
  • 纳入所有在老年人(平均或中位年龄≥65岁)中测试处方精简干预的随机对照试验,并分析其中报告ADWE作为结局的研究子样本。

主要发现

  • 共识别139项符合条件的随机对照试验,仅12项报告了ADWE。
  • 这12项研究使用了6种方法捕捉ADWE:Naranjo ADWE概率量表、针对特定撤药症状的临床监测、通过ICD-10编码识别、将ADWE作为确诊ADE的子集识别、患者/照护者自我报告、临床判断。

关键数值与推荐

  • ADWE定义为因停用药物而导致的症状或疾病状态复发。
  • 纳入研究要求平均或中位年龄≥65岁。
  • 报告ADWE的研究采用了6种捕捉方法,但原文未提供各方法的检测率或比较数值。

临床怎么用

  • 临床医生在处方精简时,可参考这6种方法之一或组合来系统监测ADWE。
  • 鉴于ADWE报告不标准化,解读处方精简试验结果时需注意ADWE捕捉方法的差异。

局限性

  • 仅12项研究符合ADWE报告分析条件,样本量小,限制了对不同捕捉方法优劣的定量比较。
  • 原文未报告各捕捉方法的敏感度、特异度或ADWE发生率等具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polypharmacy is a major risk factor for adverse drug events (ADEs), which are a common cause of hospitalization, especially among older adults. Deprescribing is a promising strategy to prevent ADEs; however, clinicians may hesitate to deprescribe for fear of causing adverse drug withdrawal events (ADWEs). Collectively, ADWEs are the re-emergence of symptoms or a disease state due to the discontinuation of a medication. Although capturing ADWEs is critical to understanding the complications that might arise from deprescribing, these events may not be routinely or systematically captured in clinical trials. OBJECTIVES: We aimed to determine the frequency of ADWE reporting, compare the strengths and limitations of different approaches, and compare the rates of the number of ADWEs detected across trials. METHODS: A systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist. The search strategy was developed with a research librarian, and studies were identified using Ovid Medline, Embase, and the Cochrane Central Register of Controlled Trials from inception to July 2, 2024. We included all randomized controlled trials testing a deprescribing intervention in older adults (mean or median age ≥ 65 years) and analyzed a subsample of the studies reporting ADWEs as an outcome. RESULTS: Among the 139 eligible studies that were identified, only 12 reported an ADWE. These studies utilized 6 approaches to capture ADWEs: Naranjo ADWE Probability Scale; clinical monitoring for specific withdrawal symptoms; identification through ICD-10 codes; identification of ADWEs as a subset of confirmed ADEs; patient/caregiver self-report; and clinical judgment. CONCLUSION: Results confirmed that few deprescribing studies capture ADWEs and there is a lack of standardized reporting. A harmonized approach to capturing ADWEs with specific criteria could ensure more consistent results in deprescribing trials, improve our understanding of this important outcome, and facilitate future meta-analyses.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Lee JJ, Bortolussi-Courval É, Filosa E, et al. Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review. J Am Geriatr Soc. 2025. PMID: 40152210. doi:10.1111/jgs.19457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。